Sulagna Banerjee

8.6k total citations
98 papers, 4.3k citations indexed

About

Sulagna Banerjee is a scholar working on Molecular Biology, Oncology and Complementary and alternative medicine. According to data from OpenAlex, Sulagna Banerjee has authored 98 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 35 papers in Oncology and 23 papers in Complementary and alternative medicine. Recurrent topics in Sulagna Banerjee's work include Pancreatic and Hepatic Oncology Research (28 papers), Natural Compounds in Disease Treatment (23 papers) and Cancer Cells and Metastasis (13 papers). Sulagna Banerjee is often cited by papers focused on Pancreatic and Hepatic Oncology Research (28 papers), Natural Compounds in Disease Treatment (23 papers) and Cancer Cells and Metastasis (13 papers). Sulagna Banerjee collaborates with scholars based in United States, India and United Kingdom. Sulagna Banerjee's co-authors include Ashok K. Saluja, Vikas Dudeja, Selwyn M. Vickers, Veena Sangwan, John Samuelson, Alice Nomura, Bhuwan Giri, Patricia Dauer, Rohit Chugh and Vineet K. Gupta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Sulagna Banerjee

97 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sulagna Banerjee United States	42	2.4k	1.5k	773	749	576	98	4.3k
Sopit Wongkham Thailand	37	2.1k 0.9×	1.5k 1.0×	888 1.1×	562 0.8×	69 0.1×	213	4.9k
Inna N. Lavrik Germany	39	3.9k 1.6×	915 0.6×	574 0.7×	1.5k 2.0×	74 0.1×	123	5.4k
José Andrés Morgado‐Díaz Brazil	32	1.6k 0.7×	502 0.3×	596 0.8×	307 0.4×	96 0.2×	87	3.2k
William N. Hait United States	38	2.8k 1.2×	2.0k 1.4×	691 0.9×	365 0.5×	122 0.2×	92	4.8k
Hassan Ashktorab United States	43	2.8k 1.2×	1.9k 1.3×	1.4k 1.8×	570 0.8×	101 0.2×	234	5.7k
Minjia Tan China	37	6.4k 2.7×	1.4k 1.0×	1.2k 1.5×	467 0.6×	71 0.1×	149	8.5k
Ye Li China	27	1.0k 0.4×	1.0k 0.7×	293 0.4×	1.1k 1.4×	59 0.1×	123	3.6k
David R. McIlwain United States	19	2.2k 0.9×	844 0.6×	392 0.5×	766 1.0×	71 0.1×	32	3.9k
Erguang Li China	36	2.0k 0.8×	551 0.4×	418 0.5×	849 1.1×	125 0.2×	87	3.9k
César López‐Camarillo Mexico	34	2.0k 0.9×	496 0.3×	1.1k 1.5×	205 0.3×	66 0.1×	160	3.4k

Countries citing papers authored by Sulagna Banerjee

Since Specialization

Citations

This map shows the geographic impact of Sulagna Banerjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sulagna Banerjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sulagna Banerjee more than expected).

Fields of papers citing papers by Sulagna Banerjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sulagna Banerjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sulagna Banerjee. The network helps show where Sulagna Banerjee may publish in the future.

Co-authorship network of co-authors of Sulagna Banerjee

This figure shows the co-authorship network connecting the top 25 collaborators of Sulagna Banerjee. A scholar is included among the top collaborators of Sulagna Banerjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sulagna Banerjee. Sulagna Banerjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gupta, Vineet K., Nikita Sharma, Brittany Durden, et al.. (2021). Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer. Cancer Research. 81(15). 4001–4013. 60 indexed citations

Dosch, Austin R., Samara P. Singh, Xizi Dai, et al.. (2021). Targeting Tumor–Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer. Molecular Cancer Therapeutics. 20(11). 2280–2290. 33 indexed citations

Kesh, Kousik, Vanessa T. Garrido, Austin R. Dosch, et al.. (2020). Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways. Cell Death and Disease. 11(11). 967–967. 29 indexed citations

Méndez, Roberto, Kousik Kesh, Nivedita Arora, et al.. (2019). Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer. Carcinogenesis. 41(5). 561–570. 87 indexed citations

Sharma, Nikita, Vineet K. Gupta, Patricia Dauer, et al.. (2019). O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability. Theranostics. 9(12). 3410–3424. 50 indexed citations

Méndez, Roberto, Sulagna Banerjee, Sanjoy K. Bhattacharya, & Santanu Banerjee. (2018). Lung inflammation and disease: A perspective on microbial homeostasis and metabolism. IUBMB Life. 71(2). 152–165. 53 indexed citations

Gupta, Vineet K., Nikita Sharma, Kousik Kesh, et al.. (2018). Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity. Cancer Letters. 439. 101–112. 50 indexed citations

Dauer, Patricia, Nikita Sharma, Vineet K. Gupta, et al.. (2018). GRP78‐mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells. Molecular Oncology. 12(9). 1498–1512. 35 indexed citations

Sethi, Vrishketan, Saba Kurtom, Mohammad Tarique, et al.. (2018). Abstract 5127: Eradication of the gut microbiota reduces cancer burden in multiple models by modulating the immune system. Cancer Research. 78(13_Supplement). 5127–5127. 1 indexed citations

10.

Dauer, Patricia, Xianda Zhao, Vineet K. Gupta, et al.. (2017). Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression. Cancer Research. 78(5). 1321–1333. 96 indexed citations

11.

Giri, Bhuwan, Vrishketan Sethi, Bharti Garg, et al.. (2017). “Heat shock protein 70 in pancreatic diseases: Friend or foe”. Journal of Surgical Oncology. 116(1). 114–122. 33 indexed citations

12.

McGinn, Olivia, Vineet K. Gupta, Patricia Dauer, et al.. (2017). Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer. Scientific Reports. 7(1). 7872–7872. 35 indexed citations

13.

Dauer, Patricia, Vineet K. Gupta, Olivia McGinn, et al.. (2017). Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer. Scientific Reports. 7(1). 1564–1564. 27 indexed citations

14.

Nomura, Alice, Kaustav Majumder, Bhuwan Giri, et al.. (2016). Inhibition of NF-kappa B pathway leads to deregulation of epithelial–mesenchymal transition and neural invasion in pancreatic cancer. Laboratory Investigation. 96(12). 1268–1278. 73 indexed citations

15.

Banerjee, Sulagna, Shrey Modi, Olivia McGinn, et al.. (2015). Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer. Clinical Cancer Research. 22(2). 415–425. 90 indexed citations

16.

Banerjee, Sulagna, Alice Nomura, Veena Sangwan, et al.. (2014). CD133+ Tumor Initiating Cells in a Syngenic Murine Model of Pancreatic Cancer Respond to Minnelide. Clinical Cancer Research. 20(9). 2388–2399. 57 indexed citations

17.

MacKenzie, Tiffany N., Nameeta Mujumdar, Sulagna Banerjee, et al.. (2013). Triptolide Induces the Expression of miR-142-3p: A Negative Regulator of Heat Shock Protein 70 and Pancreatic Cancer Cell Proliferation. Molecular Cancer Therapeutics. 12(7). 1266–1275. 118 indexed citations

18.

Sonawane, Avinash, et al.. (2012). Role of glycans and glycoproteins in disease development byMycobacterium tuberculosis. Critical Reviews in Microbiology. 38(3). 250–266. 18 indexed citations

19.

Banerjee, Sulagna, et al.. (2008). Giardia , Entamoeba , and Trichomonas Enzymes Activate Metronidazole (Nitroreductases) and Inactivate Metronidazole (Nitroimidazole Reductases). Antimicrobial Agents and Chemotherapy. 53(2). 458–464. 77 indexed citations

20.

Banerjee, Sulagna, Jike Cui, Daniel J. Kelleher, et al.. (2007). The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradation. Proceedings of the National Academy of Sciences. 104(28). 11676–11681. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact